Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
Studies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera-endemic areas of Asia. There is a need to assess the immunogenicity of the vaccine in Haiti and other populations without historical exposure to Vibrio cholerae...
Saved in:
Main Authors: | Richelle C Charles (Author), Isabelle J Hilaire (Author), Leslie M Mayo-Smith (Author), Jessica E Teng (Author), J Gregory Jerome (Author), Molly F Franke (Author), Amit Saha (Author), Yanan Yu (Author), Paul Kováč (Author), Stephen B Calderwood (Author), Edward T Ryan (Author), Regina C LaRocque (Author), Charles P Almazor (Author), Firdausi Qadri (Author), Louise C Ivers (Author), Jason B Harris (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
by: Brie Falkard, et al.
Published: (2019) -
Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.
by: Wilfredo R Matias, et al.
Published: (2016) -
Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
by: Maria Rosario Z. Capeding, et al.
Published: (2017) -
Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.
by: Fahima Chowdhury, et al.
Published: (2015) -
Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study
by: Molly F Franke, ScD, et al.
Published: (2018)